28
Feb
The American pharmaceutical and biotech company Baxter plans to invest EUR 80 million in the facilities it operates in Vienna and Orth, Lower Austria. This amount is in addition to the EUR 138 million which will be invested at the plant in Krems, Lower Austria over the coming years.
In this way, Baxter is “sustainably securing the future of its Austrian business operations”, says Karl-Heinz Hofbauer, Baxter’s Operations Manager in Vienna. Baxter continuously invests to upgrade its Austrian sites. In...